They are also in line with work profiling the sensitivity of ccRCC lines to erastin-induced cell death (80), where A498 SETD2−/− cells were more resistant to erastin than 786-O SETD2+/+ cells. This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.